Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer
Dahut, William L., Madan, Ravi A., Karakunnel, Joyson J., Adelberg, David, Gulley, James L., Turkbey, Ismail B., Chau, Cindy H., Spencer, Shawn D., Mulquin, Marcia, Wright, John, Parnes, Howard L., StVolume:
111
Language:
english
Journal:
BJU International
DOI:
10.1111/j.1464-410x.2012.11667.x
Date:
June, 2013
File:
PDF, 462 KB
english, 2013